FSNUF Stock UPDATES Fresenius Ag [Dem 50 (FSNUF) 49.0480 09/11/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fresenius Ag [Dem 50 (FSNUF) 49.0480 $FSNUF

Global Dialysis Products and Services (Hemodialysis Products, Peritoneal Dialysis Products
M2 - 1 hr 58 mins ago
Research and Markets (http://www.researchandmarkets.com/research/c8vw2r/dialysis_products) has announced the addition of the "Dialysis Products and Services Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020" report to their offering. According to the National Institutes of Health, the worldwide number of patients with chronic kidney disease is rising rapidly and is expected to rise by approximately 5% to 8% annually. Increasing prevalence of diabetes and hypertension are the two primary causes of end stage renal disease in major developing countries like China, Brazil and India and is also contributing to the growth of overall dialysis products and services market. According to the American Kidney Fund, diabetes and hypertension are responsible for 38.4% and 25% of all cases of kidney failures, respectively. Similarly, increasing geriatric population and low preference by patients above 65 years of age to opt for kidney transplant is also driving the growth of dialysis products and services market. According to the Australian Institute of Health and Welfare, the proportion of people opting for kidney transplantation decreases with age. Moreover, increasing awareness about peritoneal dialysis is expected to boost the growth of the market in the near future. The global dialysis products and services market is segmented by type of procedures and type of services. The procedures market is further segmented into hemodialysis and peritoneal dialysis. Further, the hemodialysis segment (HD) is classified into HD machine, dialyzer, access products/catheters, bloodlines, concentrates and others, which include water treatment systems and fistula needles. Hemodialysis, being the oldest and most preferred technique for dialysis procedure, Hemodialysis machines captures the largest share, of the total market in 2013. The segment is expected to lead the market during the forecast period from 2014 to 2020. Similarly, peritoneal dialysis (PD) segment is classified into concentrates/dialysate, PD machines, catheters, and transfer sets. Among these, the PD concentrates/dialysate segment is accounted for largest market share in 2013 and is expected to grow at an attractive higher growth rate during the forecast period from 2014 to 2020. The major factors responsible for the significant growth of this segment are increase in the number of patients preferring peritoneal dialysis, and rising demand of patients to be dialyzed overnight with the aid of peritoneal dialysis. Dialysis Products and Services Market, by Product type: Hemodialysis - HD Machines - Dialyzers - HD Access Products/Catheters - Bloodlines - HD Concentrates/Dialysate - Others (Water Treatment System, Fistula Needles) Peritoneal Dialysis - Concentrates/Dialysate - PD Machines - PD Catheters - PD Transfer Sets Dialysis Products and Services Market, by Type of Services: - In-center Dialysis - Home Dialysis Companies Mentioned - Asahi Kasei Corporation - B. Braun Melsungen AG - Baxter International, Inc. - C. R. Bard, Inc. - Cantel Medical Corporation - Covidien plc - DaVita Healthcare Partners, Inc. - Fresenius SE & Co. KGaA - Kawasumi Laboratories, Inc. - Medical Components, Inc. - Nikkiso Co., Ltd. - Nipro Corporation - NxStage Medical, Inc. - Rockwell Medical Technologies, Inc. For more information visit http://www.researchandmarkets.com/research/c8...s_products

DuPont appoints Ulf M. "Mark" Schneider to board
M2 - Mon Aug 04, 5:01AM CDT
Science and engineering company DuPont (NYSE D) reported on Friday the addition of Ulf M. (Mark) Schneider to its board of directors, effective Oct. 22.

Mark Schneider Elected to DuPont Board of Directors
PR Newswire - Fri Aug 01, 3:01PM CDT
DuPont today announced the election of Ulf M. "Mark" Schneider, President and CEO of Fresenius SE & Co. KGaA to its board of directors, effective Oct. 22.

Concise Analysis of the International Enteral Feeding Devices Market
M2 - Fri Mar 07, 5:54AM CST
Research and Markets (http://www.researchandmarkets.com/research/ldl6z9/enteral_feeding) has announced the addition of the "Concise Analysis of the International Enteral Feeding Devices Market" report to their offering. This report analyzes the worldwide markets for Enteral Feeding Devices in US$ Million by the following Product Categories: Enteral Feeding Pumps, Nasogastric Tubes, and Others. The report provides separate comprehensive analytics for the US Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 38 companies including many key and niche players such as: - American HomePatient, Inc. - Amsino International, Inc. - Applied Medical Technology, Inc. - Boston Scientific Corporation - C. R. Bard, Inc. - Caesarea Medical Electronics Ltd. - Cook Medical, Inc. - CONMED Corporation - CORPAK MedSystems, Inc. - Covidien Plc - Fresenius SE & Co. KGaA - Fresenius KABI AG - Kimberly-Clark Corporation - Moog Inc. - Nestl? HealthCare Nutrition - Nutricia Advanced Medical Nutrition - VYGON SA Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary 1. Industry Overview 2. Market Drivers, Trends & Issues 3. Product Overview 4. Recent Product Innovations/ Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. Latin America 7. Rest Of World IV. Competitive Landscape Total Companies Profiled: 38 (including Divisions/Subsidiaries - 52) - The United States (24) - Canada (1) - Europe (20) - France (3) - Germany (5) - The United Kingdom (6) - Rest of Europe (6) - Asia-Pacific (Excluding Japan) (6) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/ld...al_feeding

Global Burns Clinical Trials Report - H2 2013 Edition
M2 - Fri Jan 10, 8:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/4vpq56/burns_global) has announced the addition of the "Burns Global Clinical Trials Review, H2, 2013" report to their offering. This report provides elemental information and data relating to the clinical trials on Burns. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Burns. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies Participating in Burns Therapeutics Clinical Trials - MediWound Ltd. - Fibrocell Science, Inc. - Bayer AG - Plethora Solutions Holdings plc - Kuros Biosurgery AG - Klinikum St. Georg gGmbH - HealOr Ltd. - Fresenius SE & Co. KGaA - Birken AG - Baxter International Inc. Clinical Trial Overview of Top Institutes / Government - The University of Texas Medical Branch at Galveston - Massachusetts General Hospital - Shriners Hospitals for Children - U.S. Army Institute of Surgical Research - Shiraz University of Medical Sciences - National Institute of General Medical Sciences - Tehran University of Medical Sciences - Association of Dutch Burn Centres - Third Military Medical University - Johns Hopkins University For more information visit http://www.researchandmarkets.com/research/4v...rns_global

Malnutrition Global Clinical Trials Review, H2 2013: Profiles Players Such as Danone Research B.V., Royal Numico N.V. and Helen Keller International
M2 - Fri Jan 10, 5:15AM CST
Research and Markets (http://www.researchandmarkets.com/research/38jm2d/malnutrition) has announced the addition of the "Malnutrition Global Clinical Trials Review, H2, 2013" report to their offering. The clinical trial report, Malnutrition Global Clinical Trials Review, H2, 2013" provides data on the Malnutrition clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Malnutrition. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Malnutrition. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Companies Mentioned: -Abbott Laboratories -Aga Khan University -Baxter International Inc. -Baylor College of Medicine -Copenhagen University Hospital at Herlev -Cornell University -Danone Research B.V. -DaVita HealthCare Partners Inc. -Deutsche Gesellschaft fur Internationale Zusammenarbeit GmbH -Epicentre Biotechnologies -Fresenius SE & Co. KGaA -Helen Keller International -Royal Numico N.V. -University Hospital Inselspital, Berne -University of California, Davis -University of Oxford -University of Tampere -Washington University School of Medicine For more information visit http://www.researchandmarkets.com/research/38...lnutrition About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Intravenous Solutions (Parenteral Nutrition) - 2013 Global Strategic Business Report Features Giants such as Actavis, Inc and Hospira, Inc.
M2 - Mon Sep 02, 12:17PM CDT
Research and Markets (http://www.researchandmarkets.com/research/jvnnn3/intravenous#summary) has announced the addition of the "Intravenous Solutions (Parenteral Nutrition) - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Intravenous Solutions (Parenteral Nutrition) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. The report profiles 30 companies including many key and niche players such as: - Actavis Inc. - B. Braun Melsungen AG - Baxter International Inc. - Claris Lifesciences Ltd. - Fresenius SE & Co. KGaA - Fresenius Kabi AG - Sino-Swed Pharmaceutical Corp. Ltd. - Hospira Inc. - Otsuka Pharmaceutical Factory Inc. - Marck Biosciences Ltd. - Sichuan Kelun Pharmaceutical Co. Ltd. - Terumo Corporation - The Galenica Group - Vifor Pharma. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered: Normal 0 false false false MicrosoftInternetExplorer4 I. Introduction, Methodology & Product Definitions Ii. Executive Summary 1. Industry Overview 2. Intravenous Solutions 3. Parenteral Nutrition - An Overview 4. Product Launches 5. Recent Industry Activity 6. Focus On Select Global Players 7. Global Market Perspective Iii. Market Iv. Competitive Landscape For more information visit http://www.researchandmarkets.com/research/jv...us#summary About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Faex Health Adds Ebola and H. pylori AI Screening Tools

Updated Category News Views 82

A smartphone pointed at a toilet is an awkward place to hunt for medical progress, yet Faex Health is making a serious attempt to turn that daily evidence into an early-warning tool. The company has added investigational pre-screening capabilities for Ebola virus disease and Helicobacter pylori, or H. pylori, bringing its internally validated panel to 18 gastrointestinal...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 120

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
CVRx Lawsuit Puts Barostim Sales Claims Under Hard Scrutiny

Updated Category News Views 121

August 7 turned a compliance disclosure into a wrecking ball for CVRx shareholders. After the company revealed a Department of Justice civil investigative demand and cut its outlook, the stock dropped $3.55, or 60%, to close at $2.39. That is not a routine bad quarter getting punished. It is the market abruptly questioning whether the sales engine, the revenue it...

Continue Reading
Teva’s R&D Exit Puts Disclosure Questions in Focus

Updated Category News Views 114

An abrupt departure in the drug business is never just an HR memo. Teva Pharmaceutical Industries shares reportedly dropped about 8.74% after Eric Hughes, the company’s executive vice president of Global R&D and chief medical officer, left effective immediately. That kind of move rattles investors because R&D leadership is not decorative furniture at a pharmaceutical...

Continue Reading
Rosalind Franklin University’s $23.8M Scholarship Win

Updated Category News Views 80

Twenty-three million dollars can disappear fast in graduate health education, which is exactly why Rosalind Franklin University’s campaign result deserves more than a polite round of applause. The university’s five-year Empowering Scholars effort closed in June 2026 with $23,836,272 raised, clearing its $20 million target by roughly 19%. In a world where institutions...

Continue Reading
AMP Pushes Debt Wall to 2029 With €1.3B Green Notes

Updated Category News Views 108

A Refinancing With Some Actual Breathing Room Metal cans may be boring, but a debt wall arriving in 2028 is not—and Ardagh Metal Packaging has moved that problem down the road. AMP priced €1.3 billion of senior secured floating-rate green notes on November 20, 2026. The proceeds are earmarked to redeem $600 million of senior secured green notes due in 2028 and €450...

Continue Reading
Surfcomber Uses Art Week to Deepen Its Guest Appeal

Updated Category News Views 104

Miami Art Week can turn every hotel lobby into a billboard, but Surfcomber is at least trying to make its walls do some actual work. Kimpton Surfcomber Hotel is spreading local artists, participatory events, food, cocktails and retail across the property rather than hanging a few paintings and calling it culture. For a South Beach hotel with 200 feet of oceanfront, that...

Continue Reading
Surf City Seasons Put Vacation Rental Timing in Focus

Updated Category News Views 42

Summer’s Calendar Does the Talking School bells, not seagulls, appear to set the pace for Surf City’s rental market. Chris Rackley’s seasonal guide makes a pretty grounded point: the “best” time to visit Surf City, North Carolina, is not some universal magic week on a postcard. It depends on whether a traveler needs peak beach weather, wants elbow room, or...

Continue Reading
ECW Puts $52 Million Behind Learning Through Crisis

Updated Category News Views 66

A reserve fund for a classroom is not glamorous, but it may be the smartest detail in this whole $52 million commitment. Education Cannot Wait has announced support for more than 300,000 children in Lebanon, Myanmar and South Sudan, where war, flooding and displacement have ripped ordinary schooling apart. The money is meant to restore learning, provide catch-up classes...

Continue Reading
Workers Are Burning Savings as Pay Falls Behind Costs

Updated Category News Views 69

Payroll optimism has been ground into dust by the ordinary bills nobody can dodge. Monster's 2026 Cost of Living Report says 93% of employed U.S. workers feel their wages are failing to keep up with costs, barely different from 95% in both 2024 and 2025. That is not a blip, and it is not workers merely grousing about prices. Three years of nearly identical frustration...

Continue Reading

Top 5 Most Recently Viewed Articles

Alphabet's Q2 Earnings: AI Insights and Market Reactions Await

Updated Category News Views 187

Alphabet's Q2 Earnings Report: A Focus on AI Growth Alphabet (NASDAQ: GOOGL), the parent company of Google, is poised to release its second quarter earnings soon. Many analysts and investors are keenly awaiting details that might reveal how the company’s artificial intelligence (AI) endeavors are transforming into tangible revenue streams. With the surge in interest...

Continue Reading
Join the Class Action Against Dentsply Sirona for Investor Rights

Updated Category News Views 91

Important Notice for Dentsply Sirona Inc. Shareholders The Gross Law Firm has issued a notice for shareholders of Dentsply Sirona Inc. (NASDAQ: XRAY). Shareholders who acquired shares during the recently identified class period are encouraged to reach out regarding the opportunity to be appointed as lead plaintiff. Securing this position is not a prerequisite for...

Continue Reading
Major Insider Sale by James Davis at American Woodmark Revealed

Updated Category News Views 447

Insider Activity Spotlight on American Woodmark James Davis, a Board Member of American Woodmark (NASDAQ: AMWD), has made headlines recently by selling a significant number of shares, which has sparked various reactions in the market. Understanding Recent Transactions: In a recent SEC filing, it was reported that DAVIS sold 1,250 shares of American Woodmark, amounting to...

Continue Reading
Ivybrook's $5K Franchise Incentive Targets Educators

Updated Category News Views 28

Franchise ownership might just feel within reach for educators eying a new chapter, thanks to Ivybrook Academy’s fresh incentive. The renowned half-day preschool franchise is now offering a cool $5,000 cut off the initial franchise fee to educators diving into franchise ownership. It’s a nod to those who spend their days molding young minds. Opening Doors for...

Continue Reading
NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

Updated Category News Views 61

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

Continue Reading